4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide

C39H46BrN7O7 — CID 170978525

IUPAC4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide
SMILESCN1CC(Nc2cnn(C)c(=O)c2Br)CC(c2ccc(C(=O)NCCCCCCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc2)C1
InChIInChI=1S/C39H46BrN7O7/c1-45-22-26(20-27(23-45)43-29-21-42-46(2)39(53)34(29)40)24-12-14-25(15-13-24)35(49)41-18-7-5-3-4-6-8-19-54-31-11-9-10-28-33(31)38(52)47(37(28)51)30-16-17-32(48)44-36(30)50/h9-15,21,26-27,30,43H,3-8,16-20,22-23H2,1-2H3,(H,41,49)(H,44,48,50)
InChIKeyLJKUIZPIZBBLJS-UHFFFAOYSA-N
MW804.74 g/mol
LogP3.99
Rot. Bonds15

About 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide

4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide (PubChem CID 170978525) has the molecular formula C39H46BrN7O7 and a molecular weight of 804.74 g/mol. Its IUPAC name is 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide.

Molecular Properties

Compound Name4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide
PubChem CID170978525
Molecular FormulaC39H46BrN7O7
Molecular Weight804.74 g/mol
Exact Mass803.26
IUPAC Name4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide
SMILESCN1CC(Nc2cnn(C)c(=O)c2Br)CC(c2ccc(C(=O)NCCCCCCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc2)C1
InChIInChI=1S/C39H46BrN7O7/c1-45-22-26(20-27(23-45)43-29-21-42-46(2)39(53)34(29)40)24-12-14-25(15-13-24)35(49)41-18-7-5-3-4-6-8-19-54-31-11-9-10-28-33(31)38(52)47(37(28)51)30-16-17-32(48)44-36(30)50/h9-15,21,26-27,30,43H,3-8,16-20,22-23H2,1-2H3,(H,41,49)(H,44,48,50)
InChIKeyLJKUIZPIZBBLJS-UHFFFAOYSA-N
XLogP3.99
TPSA172.04 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds15
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500804.74
LogP ≤ 53.99
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide?
The IUPAC name of 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide (CID 170978525) is 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide.
What is the SMILES notation for 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide?
The canonical SMILES for 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide is CN1CC(Nc2cnn(C)c(=O)c2Br)CC(c2ccc(C(=O)NCCCCCCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc2)C1.
What is the InChIKey of 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide?
The InChIKey is LJKUIZPIZBBLJS-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H46BrN7O7/c1-45-22-26(20-27(23-45)43-29-21-42-46(2)39(53)34(29)40)24-12-14-25(15-13-24)35(49)41-18-7-5-3-4-6-8-19-54-31-11-9-10-28-33(31)38(52)47(37(28)51)30-16-17-32(48)44-36(30)50/h9-15,21,26-27,30,43H,3-8,16-20,22-23H2,1-2H3,(H,41,49)(H,44,48,50).
What are the key properties of 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide?
4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide has a molecular weight of 804.74 g/mol, XLogP of 3.99, 15 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-[(5-bromo-1-methyl-6-oxopyridazin-4-yl)amino]-1-methylpiperidin-3-yl]-N-[8-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyoctyl]benzamide is sourced from PubChem (CID 170978525), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).